Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Funder: International Atherosclerosis Society (DC, US) and R3i Foundation
Recognition: Prize for outstanding research in nuclear receptors and atherosclerosis
Award Criteria: Recognizes outstanding scientific, medical or organizational advancement in the ability to understand the functional involvement of nuclear receptors in atherosclerotic vascular disease and their athero-protective role to reduce the development of atherosclerosis.
Scope: International recognition
Recent Award Recipients
- 2024 (2nd Prize): Peter Tontonoz, MD, PhD - Awarded at the 20th International Symposium on Atherosclerosis (ISA2024) in Muscat, Oman
- 2021 (1st Prize): Hitoshi Shimano, MD, PhD - Clinical professor of the Department of Internal Medicine, Metabolism and Endocrinology at the University of Tsukuba, Japan. Awarded at ISA2021 in Kyoto, Japan
Sponsorship: Sponsored by the R3i Foundation and the International Atherosclerosis Society
What International Atherosclerosis Society actually gave
Source: IRS Form 990, 2020 — the most recent filing with itemized grants
International Atherosclerosis Society reported $6,385 in grants for 2024 as a total without an itemized list; the grant details below are from 2020, its most recent itemized filing.
- Grants in 2020
- 1
- Total given
- $10K
- Median grant
- $10K
- By dollars: New York 100%. Top recipient cities: New York, NY.
Example grants
American Austrian Foundation · New York, NY
Education grant
$10K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Heart disease
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
National Institutes of Health
Amount
$4,500,000 total
Deadline
March 10, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
National Institutes of Health
Amount
Up to $1,515,000
Deadline
February 3, 2027
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $375,000
Deadline
November 23, 2026
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
November 24, 2026
Advanced Nuclear Energy Licensing Cost-Share Grant Program
Idaho Field Office
Amount
$5,000 - $8,000,000
Deadline
November 30, 2026
NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research
Naval Research Laboratory
Amount
Varies
Deadline
December 30, 2026
Ready to apply for Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research. Now let's win it.